Investigating retinal structure and function in response to gene therapy for blindness
Retinal structure, function and response to gene therapy
This study is looking at how gene therapy can help people with inherited eye conditions that cause vision loss, and it will use special imaging to see how well their retinal cells are working, so we can find the best way to use treatments like Luxturna.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11045796 on NIH RePORTER |
What this research studies
This research focuses on understanding how gene therapy can help treat inherited retinal degenerations (IRDs) that lead to vision loss. By using advanced imaging techniques, the study aims to observe the structure and function of retinal cells in patients with these conditions. The goal is to determine the best timing and location for applying therapies like Luxturna, which is already approved for some IRDs. Patients will undergo tests to evaluate their retinal health and response to treatment, providing valuable insights into the effectiveness of gene therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with inherited retinal degenerations, particularly those with RPE65-mediated disease or other molecularly distinct IRDs.
Not a fit: Patients with retinal degenerations that are not genetically characterized or those who do not have a diagnosis of an inherited retinal degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for various forms of inherited blindness, potentially restoring vision for many patients.
How similar studies have performed: Previous research has shown promising results with gene therapies for specific inherited retinal diseases, indicating a potential for success in similar approaches.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Morgan, Jessica I.w. — University of Pennsylvania
- Study coordinator: Morgan, Jessica I.w.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.